Diabetes Board decisions

The Veteran's obstructive sleep apnea is granted as secondary to his service-connected PTSD and obesity, which are linked by medical evidence.

The Board has dismissed the appeal for an increased rating for diabetes mellitus due to withdrawal of the appeal. The skin disability claim is remanded as additional development is needed.

The Veteran's diabetes mellitus is rated at 20 percent, effective February 5, 2015. The rating for diabetic retinopathy with bilateral cataracts and glaucoma was increased to 20 percent from October 2, 2017 onwards.

The Board has remanded the case due to incomplete records and requests for additional information. The Veteran's claim of service connection for diabetes mellitus, Type II as secondary to his service-connected hypertension and/or coronary artery disease (CAD) with congestive heart failure (CHF) is pending.

The Board has remanded the case due to lack of substantial compliance with previous remand directives and for obtaining updated medical opinions regarding the etiology of the Veteran's hypertension.

The Board has granted service connection for diabetes mellitus type II on a presumptive basis due to exposure to Agent Orange. The issue of service connection for an eye disability is remanded.

The Veteran's service-connected disabilities do not preclude him from securing and following substantially gainful employment for the period of January 12, 2012 to August 9, 2012.

The Veteran's left ear hearing loss and tinnitus are granted as service connected, and his diabetes mellitus type 2 is granted on a presumptive basis due to Agent Orange exposure. The right ear hearing loss claim is remanded for further evaluation.

The Board has remanded the claims for service connection due to insufficient rationale in the previous VA examiner's opinion regarding the Veteran's claimed disabilities and their relation to his military service, particularly exposure to herbicide agents.

The Veteran's death was not caused by a service-connected disability, and the Board denied entitlement to DIC benefits.

The Board has determined that the Veteran's diabetes mellitus, type II, initially manifested during his active duty and granted service connection for this condition.

The Board has granted service connection for diabetes mellitus, type II, finding that the Veteran was exposed to herbicide agents during his service in Korea and therefore meets the criteria for presumptive service connection.

The Board has denied the Veteran's claims for service connection for ischemic heart disease and diabetes mellitus, finding that there is no evidence to support a link between these conditions and his active duty service.

The Board denied the Veteran's claim for service connection for gum disease secondary to diabetes mellitus and granted a TDIU. The Board found insufficient evidence to establish a nexus between the Veteran's service-connected diabetes mellitus and his diagnosed gum disease.

The Board has dismissed all service connection claims due to the Veteran's death.

The Board has remanded the Veteran's claims for diabetes mellitus, bilateral shoulder conditions, and hypertrophic gastritis due to a lack of adequate VA etiology opinions.

The Veteran's claims for service connection for DMII, IHD, and peripheral neuropathy of the upper and lower extremities have been remanded due to new evidence received since previous decisions. The preponderance of the evidence does not support finding that he has these conditions.

The Veteran's appeals have been dismissed as he has expressed the desire to withdraw his current appeal and refile at a later date.

The Board has granted service connection for diabetes mellitus, type II (diabetes) and Parkinson's disease due to exposure to herbicide agents in service. The Veteran was exposed to herbicides while stationed at Royal Thai Air Force Bases (RTAFB).

The Veteran's appeal for service connection for PTSD has been dismissed as the claim is moot due to a prior grant of service connection.,Service connection for Hypothyroidism and Diabetes Mellitus Type II are granted based on presumed exposure to herbicide agents during service.